A Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple Sclerosis

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 1, 2016

Primary Completion Date

May 16, 2018

Study Completion Date

May 16, 2018

Conditions

Progressive Multiple Sclerosis

Interventions

DRUG

GZ402668

"Pharmaceutical form: solution~Route of administration: subcutaneous"

DRUG

Placebo

"Pharmaceutical form: solution~Route of administration: subcutaneous"

DRUG

Acyclovir

"Pharmaceutical form: tablet~Route of administration: oral"

Trial Locations (1)

Investigational Site Number 276001, Berlin